Kosmidou I, Crowley A, Macedo L, et al. - Researchers examined 1,905 patients with left main coronary artery disease (LMCAD) who were randomized to percutaneous coronary intervention (PCI) with everolimus-eluting stents vs coronary artery bypass grafting (CABG) in the EXCEL trial, to determine the prognostic influence of resting heart rate (RHR) post-revascularization with PCI or CABG in this patient population. They measured RHR at discharge after the index hospitalization. The composite endpoint of mortality, myocardial infarction or stroke at 3 years was assessed as the main outcome measure. Regardless of treatment modality, a higher risk for adverse cardiovascular outcomes at 3 years was observed in relation to an increased RHR at discharge in patients with LMCAD undergoing revascularization.